Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03246685
Title Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SD
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Biothera
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern Medical Specialties, PLLC Tacoma Washington 98405 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field